Clinical Trial Update: Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on TOOKAD Soluble VTP for localized prostate cancer reporting on efficacy, safety, and quality of life outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TOOKAD Soluble VTP (padeliporfin)

Snippet

Sponsor: Steba Biotech S.A. | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED